Skip to main content

Duke & Deerfield Announce Four Points Innovation

Duke University and Deerfield Management Company, a healthcare investment firm, announced the creation of a major translational research collaboration. The alliance is expected to accelerate the preclinical development of new drugs for improved quality of life and cures for disease.

Read More


An inventor’s first step in the commercialization process

See More Numbers

NEW START-UP: Tellus Therapeutics

Tellus is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus’​ lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in animal models of perinatal brain injury and multiple sclerosis, and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.

Read More About Mente

VielaBio Announces U.S. FDA Approval of UPLIZNA™

Viela Bio has been approved for a drug to treat adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-AQP4 antibody-positive.

Read More


This year we’ve helped grow and develop ventures ranging from cancer therapeutics to digital health tools.

Read More

3D-Printing Gives Medical Teams COVID Protection

COVID-19 Engineering Response Team tackles powered, air-purifying respirator (PAPR)

Read More


Join us in celebrating the diverse accomplishments of Duke innovators and entrepreneurs. All month long, we’ll be showing off featured technologies, inventions, and novel ideas that illustrate the breadth of Duke discoveries. We will also highlight Duke’s innovation and entrepreneurship resources, encouraging networking among Duke inventors and the broader community. #InventedAtDuke

Join the celebration


See more Numbers

NEW START-UP: Upstream Biotechnology

Developing broad-spectrum disease-resistant crops to eliminate pesticide use, reduce production costs, and increase crop yield

Read More about Upstream

NEW START-UP: Tumult Labs

Algorithm and software platform that systematically de-identifies data such that original data cannot be reconstructed

Read More about Tumult Labs

FDA Clearance for Hernia Mesh Product Approved for Deep Blue

Read More


see More numbers